Printer Friendly

Insmed to Present at Rodman and Renshaw Healthcare Conference October 28, 2004; Presentation to Be Webcast Live.

RICHMOND, Va. -- Insmed Incorporated (NASDAQ: INSM) today announced that Geoffrey Allan, Ph.D., President and Chief Executive Officer of Insmed, will present this Thursday, October 28, 2004 at 9:25am ET during the Rodman and Renshaw Healthcare Conference. The conference is being held October 26-28, 2004 at the Waldorf-Astoria in New York.

A live audio webcast of the Company's presentation can be accessed by going to Insmed's corporate web site at www.insmed.com. A replay of the presentation will be available for 30 days.

About Insmed

Insmed Incorporated is a biopharmaceutical company focused on the development of drug candidates for the treatment of metabolic diseases with unmet medical needs. Insmed's most advanced product, SomatoKine(R), is currently in a pivotal Phase III clinical trial for the treatment of Growth Hormone Insensitivity Syndrome (GHIS). On July 20, Insmed provided the results from a six-month data analysis of the ongoing pivotal Phase III GHIS clinical trial showing a statistically significant increase (p<0.0001) in height velocity in children receiving SomatoKine(R) as a once-daily injection. For further information about Insmed and SomatoKine(R), please visit the company's corporate website at www.insmed.com.

Statements included within this press release, which are not historical in nature, may constitute forward-looking statements for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements regarding expected financial position, results of operations, cash flows, dividends, financing plans, business strategies, operating efficiencies or synergies, budgets, capital and other expenditures, competitive positions, growth opportunities for existing or proposed products or services, plans and objectives of management, demand for new pharmaceutical products, market trends in the pharmaceutical business, inflation and various economic and business trends. Such forward-looking statements are subject to numerous risks and uncertainties, including risks that product candidates may fail in the clinic or may not be successfully marketed, the company may lack financial resources to complete development of product candidates, competing products may be more successful, demand for new pharmaceutical products may decrease, the biopharmaceutical industry may experience negative market trends and other risks detailed from time to time in the company's filings with the Securities and Exchange Commission. As a result of these and other risks and uncertainties, actual results may differ materially from those described in this press release.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 
Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Oct 26, 2004
Words:386
Previous Article:Kaiser Aluminum Receives Conditional Approval of Amendment to Credit Agreement and Extension of Exclusivity.
Next Article:ObjectFX Announces SpatialFX Micro Edition for Deploying Spatial Applications on Small Wireless Devices; Provides Powerful Vector Mapping Engine for...
Topics:


Related Articles
DRAXIS to Present at Rodman & Renshaw Techvest Healthcare Conference.
Insmed to Present to Rodman and Renshaw Healthcare Conference; Presentation to be Webcast Live.
CORRECTING and REPLACING EPIX to Present at Rodman & Renshaw Techvest Global Healthcare Conference.
Insmed to Present at Rodman and Renshaw Healthcare Conference May 13, 2004; Presentation to Be Webcast Live.
Axonyx Inc. to Present at the Rodman & Renshaw Techvest 6th Annual Healthcare Conference.
OXiGENE to Present at Rodman & Renshaw Techvest 6th Annual Healthcare Conference: October 26th Presentation Available via Live Webcast.
Curis to Present at Rodman and Renshaw Techvest 6th Annual Healthcare Conference.
Regeneron to Webcast Presentations at Two Investor Conferences.
Insmed to Present at the Rodman and Renshaw 7th Annual Healthcare Conference.
Insmed to Present at Upcoming Conferences.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters